173 related articles for article (PubMed ID: 19443357)
21. [Surgical aspects of breast cancer screening at our hospital].
Márkus B; Bajner A; Csejtei A; Firisz B; Hegedus A; Kocsis E; Kovács B; Pintér G; Tóth C
Magy Seb; 2006 Oct; 59(5):375-82. PubMed ID: 17201346
[TBL] [Abstract][Full Text] [Related]
22. [Ductal carcinoma in situ: current anatomo-pathologic data].
Fiche M
Rev Med Suisse Romande; 2003 May; 123(5):295-8. PubMed ID: 15095712
[TBL] [Abstract][Full Text] [Related]
23. Is it possible to refine the indication for sentinel node biopsy in high-risk ductal carcinoma in situ?
Fraile M; Gubern JM; Rull M; Julián FJ; Serra C; Llatjós M; Culell P; Puig P; Solà M; Vallejos V; Mariscal A; Janer J; Deulofeu P; Fusté F
Nucl Med Commun; 2006 Oct; 27(10):785-9. PubMed ID: 16969260
[TBL] [Abstract][Full Text] [Related]
24. Recent advances and current controversies in the management of DCIS of the breast.
Sakorafas GH; Farley DR; Peros G
Cancer Treat Rev; 2008 Oct; 34(6):483-97. PubMed ID: 18490111
[TBL] [Abstract][Full Text] [Related]
25. Ductal carcinoma in-situ: an update for clinical practice.
Patani N; Khaled Y; Al Reefy S; Mokbel K
Surg Oncol; 2011 Mar; 20(1):e23-31. PubMed ID: 21106367
[TBL] [Abstract][Full Text] [Related]
26. Evaluating the role of sentinel lymph node biopsy in patients with DCIS treated with breast conserving surgery.
James TA; Palis B; McCabe R; Pardo JA; Alapati A; Ukandu O; Serres SK; Zhang J; Mele A; Facktor M; Shulman LN
Am J Surg; 2020 Sep; 220(3):654-659. PubMed ID: 31964523
[TBL] [Abstract][Full Text] [Related]
27. Identifying factors contributing to reduced breast tumor size: a longitudinal study.
Rovera F; Dionigi G; Riva C; Chiaravalli A; Corben AD; Bianchi V; Cinquepalmi L; Boni L; Dionigi R
Int J Surg; 2008; 6 Suppl 1():S97-S100. PubMed ID: 19131284
[TBL] [Abstract][Full Text] [Related]
28. Sentinel lymph node biopsy in low risk settings.
Tasoulis MK; Hughes T; Babiera G; Chagpar AB
Am J Surg; 2017 Sep; 214(3):489-494. PubMed ID: 28335989
[TBL] [Abstract][Full Text] [Related]
29. [Management of ductal carcinoma in situ by the pathologist: current questions].
Arnould L; Caron Y; Sigal-Zafrani B
Ann Pathol; 2003 Dec; 23(6):534-46. PubMed ID: 15094591
[TBL] [Abstract][Full Text] [Related]
30. The effect of margins on the clinical management of ductal carcinoma in situ of the breast.
Meijnen P; Gilhuijs KG; Rutgers EJ
J Surg Oncol; 2008 Dec; 98(8):579-84. PubMed ID: 19072848
[TBL] [Abstract][Full Text] [Related]
31. [Surgical treatment of non-palpable breast tumors].
Lázár G; Ormándi K; Hajnal PR; Zöllei I; Szentpáli K; Paszt A; Kallai A; Kahán Z; Balogh A
Orv Hetil; 2002 Jan; 143(2):77-81. PubMed ID: 11868452
[TBL] [Abstract][Full Text] [Related]
32. Are encapsulated papillary carcinomas of the breast in situ or invasive? A basement membrane study of 27 cases.
Esposito NN; Dabbs DJ; Bhargava R
Am J Clin Pathol; 2009 Feb; 131(2):228-42. PubMed ID: 19141383
[TBL] [Abstract][Full Text] [Related]
33. Occult nipple involvement in breast cancer: clinicopathologic findings in 316 consecutive mastectomy specimens.
Brachtel EF; Rusby JE; Michaelson JS; Chen LL; Muzikansky A; Smith BL; Koerner FC
J Clin Oncol; 2009 Oct; 27(30):4948-54. PubMed ID: 19720921
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of oncogenic markers in ductal carcinoma in situ of the breast: a clinicopathologic study.
Altintas S; Lambein K; Huizing MT; Braems G; Asjoe FT; Hellemans H; Van Marck E; Weyler J; Praet M; Van den Broecke R; Vermorken JB; Tjalma WA
Breast J; 2009; 15(2):120-32. PubMed ID: 19292797
[TBL] [Abstract][Full Text] [Related]
35. Clonality analysis of intraductal proliferative lesions using the human androgen receptor assay.
Li H; Chen Q; Zhu R; Gu DH; Zhu HG
Neoplasma; 2007; 54(6):490-4. PubMed ID: 17949232
[TBL] [Abstract][Full Text] [Related]
36. [Bilateral ductal carcinoma in situ of the breast: independent events or bilateral disease?].
André G; Tunon-de-Lara C; Macgrogan G; Laharie-Mineur H; Bussieres JE; Valentin F; Barreau B; Dilhuydy MH; Dilhuydy JM; Mauriac L; Debled M; Durand M; Mathoulin S; Avril A
J Gynecol Obstet Biol Reprod (Paris); 2007 May; 36(3):260-6. PubMed ID: 17376610
[TBL] [Abstract][Full Text] [Related]
37. Pro: SLNB in DCIS.
Fuhrman GM
Ann Surg Oncol; 2007 Mar; 14(3):1005-6. PubMed ID: 17180481
[No Abstract] [Full Text] [Related]
38. Factors influencing the decision to offer immediate breast reconstruction after mastectomy for ductal carcinoma in situ (DCIS): the Institut Gustave Roussy Breast Cancer Study Group experience.
Naoura I; Mazouni C; Ghanimeh J; Leymarie N; Garbay JR; Karsenti G; Sarfati B; Leduey A; Kolb F; Delaloge S; Rimareix F
Breast; 2013 Oct; 22(5):673-5. PubMed ID: 23357706
[TBL] [Abstract][Full Text] [Related]
39. Breast pathology: rationale for adopting the ductal intraepithelial neoplasia (DIN) classification.
Tavassoli FA
Nat Clin Pract Oncol; 2005 Mar; 2(3):116-7. PubMed ID: 16264885
[No Abstract] [Full Text] [Related]
40. Solid-papillary carcinoma of the breast: clinicopathological study of 20 cases.
Otsuki Y; Yamada M; Shimizu S; Suwa K; Yoshida M; Tanioka F; Ogawa H; Nasuno H; Serizawa A; Kobayashi H
Pathol Int; 2007 Jul; 57(7):421-9. PubMed ID: 17587241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
